Island Pharmaceuticals Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.islandpharmaceuticals.com

Country

Australia

Exchange

ASX

Founded 2017

Island Pharmaceuticals Limited, a drug repurposing company develops antiviral therapeutics for antiviral therapeutics in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and mosquito borne diseases. Founded in 2017, Island Pharmaceuticals is based in Hawthorn East, Australia.

Key Stats

52-Week Range

A$0.14A$0.63

Beta0.12

Trailing P/EN/A

Forward P/E-8.19

Trailing EPS-0.03

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceA$1.60

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.